{"data":{"id":"us-mt/50-43-101","jurisdiction":"us-mt","citation":"50-43-101","heading":"Purpose.","body":"The purpose of this part is to provide for the continuation of medication initiated by a physician for multiple sclerosis. This medication includes the substances described in this part and has been found to be effective in alleviating the symptoms of multiple sclerosis.","path":["TITLE 50. HEALTH AND SAFETY","CHAPTER 43. CALCIUM-EAP, HARNOSAL, AND PHOSETAMIN","Part 1. General Provisions"],"source_url":"https://mca.legmt.gov/bills/mca/title_0500/chapter_0430/part_0010/section_0010/0500-0430-0010-0010.html","current_through":"Montana Code Annotated 2025","vintage":"","retrieved_at":"2026-09-14T04:56:28Z","sha256":"caab42f150173fd517d85f44cc9cbe258e3e82d8b8ea590701ed7e843fd9a5e4","source_id":"us-mt","stale":false,"prev":"us-mt/50-42-107","next":"us-mt/50-43-102"},"notice":"GroundRules: Original legal text. Not legal advice."}